Cohesion and empowerment! Shandong Guoxin and his entourage visited Yinfeng Cryogenic Medical Research Center for visits and exchanges
Release time:
2023-09-05
On September 5th, Zhou Peng and Zhao Quanan, general managers of Jinan Yinfeng Wealth Center of Shandong International Trust Co., Ltd., and Yang Qin, an expert of Beijing family office trust, visited the Cryogenic Medicine Research Center of Shandong Yinfeng Life Science Research Institute.
During the visit, Shandong Guoxin and his entourage learned in detail about the scientific research progress and application prospects of cryogenic medicine, learned for the first time about the history of Yinfeng's life extension program and the story behind "Asia's first human cryopreservation", and expressed concern and recognition for this forward-looking and challenging research project, and looked forward to the future vision and bright future of cryogenic medicine.
Subsequently, at the symposium, the Yinfeng cryogenic medical team comprehensively introduced the operation, business sectors and scientific research development of Yinfeng Group and the Cryogenic Medical Research Center; Shandong Guoxin and his entourage introduced the comprehensive strength and business layout of Shandong Guoxin Company in depth. At the same time, the two sides discussed the integration of resource advantages and service models, in order to find opportunities, promote model innovation, empower each other, and provide better services for members of both sides.
Through this visit and exchange, the two sides initially reached a cooperation intention, which laid a good foundation for the next step of cross-industry cooperation.
相关介绍
Shandong International Trust Co., Ltd. (hereinafter referred to as "Shandong Guoxin"), established in 1987, is a non-bank financial institution approved by the People's Bank of China and the People's Government of Shandong Province. As a comprehensive financial service institution controlled by Luxin Group, Shandong Guoxin was listed on the Hong Kong Stock Exchange in December 2017, becoming the first mainland trust to land in the international capital market and the first Hong Kong stock trust.
Shandong Guoxin has always adhered to the principle of seeking progress while maintaining stability and improving quality, comprehensively using a variety of financial tools to serve economic and social development, effectively grafting the money market, capital market and real economy, and building a development pattern of "rooted in Shandong, radiating the whole country and going international", and has won the highest grade A in China's trust industry rating and the highest AAA grade in the performance evaluation of local financial enterprises in Shandong Province for many times, and has developed into a comprehensive financial and wealth management service provider with leading comprehensive strength and high brand reputation.
Latest developments
With infinite hope for future medical technology, I applied to become a member of the Yinfeng Life Extension Program and volunteered to contribute to cryobiology in a hundred years by becoming a cryonics volunteer. I also believe that preservation in China is safer.
As a distinguished emblem of technological innovation in Shandong, Yinfeng's Life Continuation Project will continue to build a bridge for domestic and international government research and academic exchange, continually strengthen scientific collaborations and result transformations with global research institutions, consistently contribute to the development of cryobiomedicine, and inject continuous hope into the shared ideal of extending human life.
Exploring life sciences and anticipating future miracles. The Yinfeng Life Extension Program members' online exchange meeting successfully concluded at 9:30 AM. Aaron Drake, Director of the Clinical Response Center at Shandong Yinfeng Life Science Research Institute (hereafter referred to as Yinfeng Institute), and the cryonics team participated in this exchange event.